LSE creators

Number of items: 27.
None
  • Srivastava, Divya, Scarbrough, Harry, Stavropoulou, Charitini (2020). Current regulatory challenges to support the spread of digital health technologies: CHIR Report. (CHIR Reports). Centre for Healthcare Innovation Research, City, University of London.
  • Srivastava, Divya, McGuire, Alistair (2016). The determinants of access to health care and medicines in India. Applied Economics, 48(17), 1618-1632. https://doi.org/10.1080/00036846.2015.1105921
  • Srivastava, Divya, McGuire, Alistair (2015). Patient access to health care and medicines across low-income countries. Social Science & Medicine, 133, 21-27. https://doi.org/10.1016/j.socscimed.2015.03.021
  • Mladovsky, Philipa, Srivastava, Divya, Cylus, Jonathan, Karanikolos, Marina, Evetovits, Tamás, Thomson, Sarah, McKee, Martin (2012). Health policy in the financial crisis. Eurohealth, 18(1), 3-6.
  • Mladovsky, Philipa, Srivastava, Divya, Cylus, Jonathan, Karanikolos, Marina, Evetovits, Tamás, Thomson, Sarah, McKee, Martin (2012). Health policy responses to the financial crisis in Europe. (Policy summary 5). World Health Organization on behalf of the European Observatory on Health Systems and Policies.
  • Le Grand, Julian, Srivastava, Divya (2009). Incentives for prevention: Health England report no. 3. Health England.
  • Wismar, Matthias, McKee, Martin, Ernst, Kelly, Srivastava, Divya, Busse, Reinnhard (2008). Health targets in Europe: learning from experience. European Observatory on Health Systems and Policies.
  • Srivastava, Divya (2008). A country level report on the pharmaceutical sector in India part one: Institutions involved in pharmaceutical regulation. Department for International Development.
  • Le Grand, Julian, Srivastava, Divya (2008). Economic incentives for long-term health gain: a report for Health England. Health England.
  • Srivastava, Divya (2008). Is prevention better than cure?: a review of the evidence. Research note for the European Commission, DG Employment and Social Affairs.
  • Mossialos, Elias, Srivastava, Divya (2008). Pharmaceutical policies in Finland - challenges and opportunities. (Observatory Studies Series 10). World Health Organization.
  • Mossialos, Elias, Srivastava, Divya (2008). Pharmaceutical policies in Finland: challenges and opportunities. European Observatory on Health Systems and Policies.
  • Wismar, Matthias, Ernst, Kelly, Srivastava, Divya, Busse, Reinnhard (2006). Health targets and (good) governance. Euro Observer, 8(1), 1-5.
  • Figueras, Josep, Lessof, S., Srivastava, Divya (2006). Managing paradox. In Marinker, Marshall (Ed.), Constructive Conversations About Health: Policy and Values (pp. 197-214). Radcliffe Publishing.
    • Public
  • Orgad, Shani, Srivastava, Divya, Olaleye, Diana (2025). Listening in times of crisis: the value and limits of radio phone-in shows. Media, Culture & Society, 47(4), 753 - 770. https://doi.org/10.1177/01634437241308729 picture_as_pdf
  • Conolly, Georgina, Costa-Font, Joan, Srivastava, Divya (2025). Did COVID-19 reduce the digital divide? A systematic review. Health Policy and Technology, 14(2). https://doi.org/10.1016/j.hlpt.2025.100979 picture_as_pdf
  • Gille, Felix, Maaß, Laura, Ho, Benjamin, Srivastava, Divya (2025). From theory to practice: viewpoint on economic indicators for trust in digital health. Journal of Medical Internet Research, 27, https://doi.org/10.2196/59111 picture_as_pdf
  • Srivastava, Divya (2024). AI: a use case for global health. LSE Public Policy Review, 3(3). https://doi.org/10.31389/lseppr.109 picture_as_pdf
  • Srivastava, Divya (22 March 2024) What role should AI play in global health? LSE European Politics and Policy (EUROPP) blog. picture_as_pdf
  • Orgad, Shani, Srivastava, Divya, Olaleye, Diana (19 February 2024) Community as an antidote to “Broken Britain”. British Politics and Policy at LSE. picture_as_pdf
  • Srivastava, Divya, Van Kessel, Robin, Delgrange, Marine, Cherla, Avi, Sood, Harpreet, Mossialos, Elias (2023). A framework for digital health policy: insights from virtual primary care systems across five nations. PLOS Digital Health, 2(11). https://doi.org/10.1371/journal.pdig.0000382 picture_as_pdf
  • van Kessel, Robin, Srivastava, Divya, Kyriopoulos, Ilias, Monti, Giovanni, Novillo-Ortiz, David, Milman, Ran, Zhang-Czabanowski, Wojciech Wilhelm, Nasi, Greta, Stern, Ariel Dora & Wharton, George et al (2023). Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping. JMIR mHealth and uHealth, 11, https://doi.org/10.2196/49003 picture_as_pdf
  • Srivastava, Divya (2023). Promoting the systematic use of real-world data and real-world evidence for digital health technologies across Europe: a consensus framework. Health Economics, Policy and Law, 18(4), 395-410. https://doi.org/10.1017/S1744133123000208 picture_as_pdf
  • Bigio, Jacob, Hannay, Emma, Pai, Madhukar, Alisjahbana, Bachti, Das, Rishav, Huynh, Huy Ba, Khan, Uzma, Mortera, Lalaine, Nguyen, Thu Anh & Safdar, Muhammad Aamir et al (2023). The inclusion of diagnostics in national health insurance schemes in Cambodia, India, Indonesia, Nepal, Pakistan, Philippines and Viet Nam. BMJ Global Health, 8(7). https://doi.org/10.1136/bmjgh-2023-012512 picture_as_pdf
  • Srivastava, Divya, McGuire, Alistair (2014). Analysis of prices paid by low-income countries: how price sensitive is government demand for medicines? BMC Public Health, 14(1), p. 767. https://doi.org/10.1186/1471-2458-14-767
  • Srivastava, Divya, McGuire, Alistair (2013). Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? (LSE Health working paper series in health policy and economics 35/2013). LSE Health.
  • Srivastava, Divya (2011). An analysis of the determinants of access to medicines and health care in developing country settings [Doctoral thesis]. London School of Economics and Political Science. picture_as_pdf